Jpmorgan Chase & CO Biolife Solutions Inc Call Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BLFS
# of Institutions
199Shares Held
45MCall Options Held
8.2KPut Options Held
4K-
Casdin Capital, LLC New York, NY8.71MShares$221 Million16.93% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$139 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.2MShares$81.3 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.85MShares$72.3 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.58MShares$40.1 Million0.2% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.08B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...